HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Preventive Oncology

Preventive oncology is a vital aspect of healthcare that focuses on strategies to minimize the risk of cancer development and promote early detection. It encompasses a range of interventions aimed at reducing the incidence of cancer and improving overall health outcomes. Key components of preventive oncology include lifestyle modifications, vaccination, and screening programs. Adopting a healthy lifestyle plays a pivotal role in cancer prevention. Regular physical activity, a balanced diet rich in fruits and vegetables, limited alcohol consumption, and avoidance of tobacco products contribute significantly to reducing the risk of various cancers. These lifestyle choices not only enhance overall well-being but also create a protective environment against the development of cancerous cells. Vaccination against certain infectious agents known to cause cancer is another crucial preventive measure. For instance, vaccines targeting human papillomavirus (HPV) and hepatitis B virus can prevent infections that may lead to cervical and liver cancers, respectively. By immunizing individuals against these high-risk viruses, preventive oncology aims to curb the incidence of associated cancers. Screening programs are integral to early cancer detection, allowing for timely intervention and improved treatment outcomes. Mammography, colonoscopy, and Pap smears are examples of screening tests that aid in identifying cancer at its earliest stages when it is most treatable. These programs are particularly important for individuals with a higher risk due to factors such as age, family history, or certain genetic predispositions. In conclusion, preventive oncology emphasizes the importance of proactively addressing lifestyle factors, utilizing vaccines, and implementing screening initiatives to mitigate the risk of cancer. By promoting awareness and encouraging regular health check-ups, preventive oncology plays a pivotal role in reducing the burden of cancer on individuals and society as a whole.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp